Statistics for Transgene SA (id:10819 TNG)
Valuation metrics
Market cap
102.76M
Enterprise value
98.39M
Trailing P/E (ttm)
Forward P/E
-1.31
PEG ratio
-1.31
Price/Sales (ttm)
15.82
Price/Book (mrq)
Enterprise Value/Revenue
15.15
Enterprise Value/EBITDA
-3.28
Overview
Shares outstanding
132.29M
Float
26.55M
Shares short
% Held by insiders
0.74%
% Held by institutions
0.01%
Average volume (10 days)
28.97K
Average volume (90 days)
Price summary
52-Week low
0.74
52-Week high
1.52
52-Week change
-86.68%
Beta
0.80
50-Day moving average
0.97
200-Day moving average
1.11
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
December 31th, 2023
Profitability
Profit margin
0.00%
Operating margin
-491.36%
Operational effectiveness
Return on assets
-38.85%
Return on equity
-214.69%
Income statement
Revenue (ttm)
0.06
Revenue per share (ttm)
0.06
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
-30,044,000.00
Net income to common (ttm)
-22,911,000.00
Diluted EPS (ttm)
-0.22
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
15.32M
Total cash per share (mrq)
0.15
Total debt (mrq)
36.78M
Total Debt/Equity (mrq)
2.36
Current ratio (mrq)
157.10%
Book value per share (mrq)
-0.01
Cash flow
Cash flow statement
-35,544,000.00
Levered free cash flow (LFCF)
5.60M